sun pharma

Sun Pharma at risk from Trump's latest tariffs, impact on Indian firms minimal

Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US

Published on Sep 28, 2025 12:48 PM IST

India is largely an exporter of generic drugs to the US, which do not fall under the purview of Trump tariff on pharma imports.

Updated on Sep 26, 2025 04:45 PM IST

India makes and exports low-cost generic drugs to the US and not branded, patented drugs, which have come under 100% US tariffs on pharma.

Updated on Sep 27, 2025 09:03 AM IST

The share prices of Indian pharma companies were hit on Friday after Trump's 100 per cent tariff announcement.

Updated on Sep 27, 2025 12:04 AM IST

The logo of Sun Pharma installed on the facade of its corporate office in Mumbai.

Updated on Sep 26, 2025 10:09 AM IST

News / Topic / Sun Pharma